ArticleAmerican journal of cancer research2019

Genome-scale CRISPR activation screening identifies a role of ELAVL2-CDKN1A axis in paclitaxel resistance in esophageal squamous cell carcinoma.

Wen-Si Zhao et al.PubMed ↗Full text ↗

No numbers read from the abstract.